Table of Contents

1. Introduction: Are Breast Implants Safe?
2. What Is BIA-ALCL?
3. How Common Is BIA-ALCL?
4. Why Does BIA-ALCL Occur?
5. Symptoms: What to Watch For
6. How Is BIA-ALCL Diagnosed?
7. BIA-ALCL Treatment Options
8. Prevention & Risk Reduction
9. Dr. Milan Doshi’s Safety Approach
10. BIA-ALCL vs Breast Implant Illness (BII)
11. Local Perspective: Awareness in India
12. FAQs: Common Questions
13. Final Thoughts & Call to Action

Introduction: Are Breast Implants Safe?

Breast augmentation helps many women restore confidence and femininity. At Allure Medspa, Mumbai, we’ve performed 12,000+ cosmetic procedures with high satisfaction. A frequent question today is: “Can breast implants cause cancer?”

The answer is nuanced. One rare condition to understand is BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma). Below is a clear, patient-friendly guide separating fact from fear.

What Is BIA-ALCL?

BIA-ALCL is a rare non-Hodgkin’s lymphoma of the immune system (not breast tissue). It typically develops in the capsule (scar tissue) or fluid around an implant, and has been most strongly associated with textured-surface implants. It’s distinct from common implant issues such as capsular contracture or rupture.

How Common Is BIA-ALCL?

• Global risk estimates have ranged roughly from 1 in 3,000 to 1 in 30,000 among patients with textured implants.
• Some studies report higher risk with specific macro-textured devices.
• Smooth implants have significantly lower known risk compared to textured types.

Many regulators and surgeons discourage the use of macro-textured implants. At our practice, we preferentially use smooth, cohesive gel implants to prioritise safety.

Why Does BIA-ALCL Occur?

Current evidence suggests a multi-factor origin, potentially involving:

• Chronic inflammation associated with certain implant surface textures
• Host factors/genetic predisposition
• Bacterial biofilm on implant surfaces

Symptoms of BIA-ALCL: What to Watch For

BIA-ALCL most often presents years after augmentation (commonly 8–10 years post-implantation). Seek evaluation for:

• Persistent swelling or late seroma (fluid) around the implant
• Unexplained pain, tightness, or a palpable lump
• Redness, sudden asymmetry, or shape change

These signs can also occur with benign conditions, but early medical assessment is essential. When found early, outcomes are typically excellent.

How Is BIA-ALCL Diagnosed?

At Allure Medspa, we follow international best-practice algorithms:

1. Ultrasound or MRI to identify fluid collections or masses
2. Fine-needle aspiration of fluid for cytology and markers
3. CD30 immunohistochemistry to confirm diagnosis
4. PET-CT if malignancy is suspected to assess extent

BIA-ALCL Treatment Options

The prognosis is generally very good when treated early.

• Localized disease: Total capsulectomy (implant + capsule removal). Systemic therapy is often unnecessary.
• Advanced disease: Surgery plus oncology-guided therapy (e.g., CHOP). In select cases, radiotherapy may be considered.

Prevention & Risk Reduction

• Choose smooth-surface, FDA-approved/CE-certified implants.
• Meticulous sterile technique and pocket control to minimise bacterial contamination.
• Routine follow-ups and prompt review of late swelling or shape changes.
• Discuss personal risk factors and device options during consultation.

Dr. Milan Doshi’s Safety Approach

• Device selection: Preference for smooth cohesive gel implants.
• Technique: Closed-system handling; minimal-touch implantation; precise pocket creation.
• Aftercare: Structured follow-up and long-term monitoring.
• Education: Clear counselling on benefits, risks, and alternatives—including revision or explant when appropriate.

Breast Implant Cancer vs Breast Implant Illness (BII)

• BIA-ALCL: Rare lymphoma in the capsule/seroma; diagnosable with CD30 testing; typically curable when detected early.
• BII: A patient-reported cluster of symptoms (e.g., fatigue, brain fog, joint pain). Not a formal cancer diagnosis; some patients elect explant to address symptoms.

Local Perspective: Awareness in India

Awareness of implant safety is increasing across India. Patients in Mumbai, Delhi, Bengaluru and beyond now routinely seek:

• Risk counselling and screening
• Safe explant/revision options
• Long-term postoperative support

Allure Medspa serves patients nationwide and internationally with evidence-based protocols and transparent guidance.

FAQs: Most Googled Questions on BIA-ALCL

Q1. Is BIA-ALCL fatal?

Ans. With early diagnosis and complete capsulectomy, outcomes are overwhelmingly favourable.

Q2. Can breast implant illness turn into cancer?

Ans. BII is not cancer. BIA-ALCL is a separate, rare lymphoma of the capsule/seroma.

Q3. Can I still get implants if I’m worried about BIA-ALCL?

Ans. Yes—discuss risk-reducing choices (e.g., smooth implants) and personalised planning with a qualified surgeon.

Q4. Should I remove my implants if I have no symptoms?

Ans. Prophylactic removal is generally not recommended without symptoms or findings; individualise with your surgeon.

---

Final Thoughts & Call to Action

BIA-ALCL is rare—and modern protocols help prevent, detect, and treat it effectively. If you have concerns about your implants or want balanced guidance on augmentation choices:

📞 Call: +91 8291863159  |  📅 Book online: Schedule a consultation »  |  📖 Learn more: Breast Augmentation Overview »